Merck & Co Inc (MRK)

78.25 -2.06  -2.57% NYSE Apr 7, 16:59 Delayed 2m USD

Merck Profit Margin (Quarterly):

19.85% for Dec. 31, 2019
View 4,000+ financial data types
Browse...
View Full Chart

Profit Margin (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Profit Margin (Quarterly) Data

View and export this data going back to 1984. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Dec. 31, 2019 19.85%
Sept. 30, 2019 15.33%
June 30, 2019 22.70%
March 31, 2019 26.95%
Dec. 31, 2018 16.61%
Sept. 30, 2018 18.07%
June 30, 2018 16.31%
March 31, 2018 7.33%
Dec. 31, 2017 -10.03%
Sept. 30, 2017 -0.54%
June 30, 2017 19.60%
March 31, 2017 16.44%
Dec. 31, 2016 -5.88%
Sept. 30, 2016 20.73%
June 30, 2016 12.24%
March 31, 2016 12.08%
Dec. 31, 2015 9.56%
Sept. 30, 2015 18.13%
June 30, 2015 7.02%
March 31, 2015 10.11%
Dec. 31, 2014 69.80%
Sept. 30, 2014 8.48%
June 30, 2014 18.33%
March 31, 2014 16.61%
Dec. 31, 2013 6.90%
   
Sept. 30, 2013 10.19%
June 30, 2013 8.23%
March 31, 2013 14.93%
Dec. 31, 2012 7.73%
Sept. 30, 2012 15.05%
June 30, 2012 14.56%
March 31, 2012 14.82%
Dec. 31, 2011 12.30%
Sept. 30, 2011 14.07%
June 30, 2011 16.66%
March 31, 2011 9.01%
Dec. 31, 2010 -4.40%
Sept. 30, 2010 3.07%
June 30, 2010 6.63%
March 31, 2010 2.62%
Dec. 31, 2009 64.33%
Sept. 30, 2009 56.60%
June 30, 2009 26.38%
March 31, 2009 26.46%
Dec. 31, 2008 27.26%
Sept. 30, 2008 18.38%
June 30, 2008 29.22%
March 31, 2008 56.73%
Dec. 31, 2007 -26.12%
Sept. 30, 2007 25.11%

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Benchmarks

Benchmarks
Amgen Inc 27.48%
Gilead Sciences Inc 45.86%
Johnson & Johnson 19.33%

Profit Margin (Quarterly) Range, Past 5 Years

Minimum -10.03% Dec 2017
Maximum 26.95% Mar 2019
Average 12.76%
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.